Application of Wharton jelly-derived mesenchymal stem cells in patients with pulmonary fibrosis.

ABSTRACT: Pulmonary fibrosis is a devastating disease that eventually leads to death and respiratory failure. Despite the wide range of drugs, including corticosteroids, endothelin antagonist, and pirfenidone, there is no effective treatment, and the only main goal of treatment is to alleviate the symptoms as much as possible to slow down the progression of the disease and improve the quality of life. Lung transplantation may be a treatment option for a few people if pulmonary fibrosis develops and there is no established treatment. Pulmonary fibrosis caused by the COVID19 virus is another problem that we face in most patients despite the efforts of the international medical communities. Therefore, achieving alternative treatment for patients is a great success. Today, basic research using stem cell

SUBMITTER: Saleh M 

PROVIDER: S-EPMC8845364 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature